Return to content in this issue

Successful Desensitization to Daratumumab After a Severe Life-threatening Reaction in a Patient With Refractory Multiple Myeloma

Carrón-Herrero A¹*, Solano-Solares E¹*, Geraldine Rita C², Rodríguez-Martín E², Ruedas Á³, Barbolla I³, Berges-Gimeno MP<sup>1,4

1</sup>Allergology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain
²Immunology Department Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain
³Internal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain
⁴Spanish Thematic Network and Co-operative Research Centres, ARADyAL, Spain
*Both authors contributed equally and should be considered first authors.

J Investig Allergol Clin Immunol 2021; Vol 31(6) : 511-513
doi: 10.18176/jiaci.0678